(May 13, 2020 / JNS) A bipartisan bill was introduced in the U.S. House of Representatives on Tuesday that would authorize a new partnership program to enhance cooperation between the United States and Israel to develop innovative approaches for treating and potentially curing COVID-19.
Reps. David Kustoff (R-Tenn.), Chris Pappas (D-N.H.), Lance Gooden (R-Texas) and Tom Suozzi (D-N.Y.) introduced the Expanding Medical Partnerships with Israel to Lessen Dependence on China Act.
The coronavirus pandemic originated in Wuhan, China. The exact source of the virus has been disputed with some claiming that it came manufactured from a lab and others stating that it emanated from the use of wet markets, where fish and meat are butchered and sold.
“The United States and Israel are world leaders in the medical technology industry,” said Kustoff. “It’s long past time we end our dependence on China and enhance our partnership with our great ally Israel to develop innovative medical technologies to treat and cure COVID-19. It’s in the benefit of not only our two countries, but also the rest of the world.”
In addition to the bill, the House members are also pushing for the inclusion of $12 million, which would be matched by Israel, to fund the new research partnership in any future legislation to address the impact of the coronavirus pandemic.
A similar bill was introduced in the Senate last month by Sens. Chris Coons (D-Del.) and Ted Cruz (R-Texas).
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.